Skip to main content
Professional Technical IVT

graft-versus-host disease

Also written as: GVHD — graft-versus-host disease

A potentially life-threatening complication following bone marrow or stem cell transplantation where donor cells attack recipient tissues.

Full Definition

Graft-versus-host disease (GVHD) is a major complication of allogeneic hematopoietic stem cell transplantation in which donor immune cells recognize the recipient's tissues as foreign and mount an immune response against them. GVHD can be acute (occurring within 100 days of transplant) or chronic (occurring after 100 days), affecting skin, liver, gastrointestinal tract, and other organs. While GVHD can be severe, mild graft-versus-host effects may also provide beneficial graft-versus-leukemia activity.

Usage

Usage note: Always use hyphens in the full term; GVHD abbreviation acceptable after first use; distinguish from graft-versus-leukemia effect.

In Context

  • "The patient developed acute graft-versus-host disease affecting the skin and liver." — Post-transplant follow-up note
  • "Chronic GVHD prophylaxis included methotrexate and tacrolimus." — Transplant protocol

Also known as

GVHD

Contrasted with

graft-versus-leukemia effect graft tolerance

Don't confuse with

graft rejection graft-versus-leukemia

Editors from these organisations have used our services since 1998

Reuters BBC Oxford University Press Penguin Random House Springer Microsoft Suncor Energy United Nations Fisher Investments IBM The Home Depot KODAK CHEVRON